Advertisement

Cancer drugs News

alt
In today's DNA, Zee News' Rohit Ranjan will analyse the fake cancer medicines racket running in the country.
alt
Preclinical experiments by researchers at University of Alabama at Birmingham (UAB) in the US suggest the cancer drugs vorinostat, belinostat and panobinostat might help treat HPVs.
alt
The researchers found that of cancer drugs approved by the European Medicines Agency (EMA) between 2009 and 2013, 57 percent (39/68) had no supporting evidence of better survival or quality of life when they entered the market.
alt
The team also found an LxxLL motif (a common sequence of amino acids) in the p85a protein, which acts as an intermediary between RXRa and PI3K.
alt
The new combination approach prevents cancer cells from changing their diet (metabolically inflexible), and effectively starves them, by preventing them from using any other available types of bio-fuels.
alt
The prices of other important cancer drugs, such as Nanoxel (Rs 1,035) and Frastim (Rs 1,273) have been slashed by 55 per cent and 51 per cent respectively.
alt
The 'post office' of the cell -- or the Golgi apparatus as it is more commonly known -- has the ability to package proteins in order to transport them to other parts of the cell or to deliver them to areas outside of the cell.
alt
Professor Warren Chan from the University of Toronto has spent the last decade figuring out how to deliver chemotherapy drugs into tumours - and nowhere else.
alt
When GTP levels are increased and utilised as fuel by rampaging cancer cells, its ability to perform its primary goals is compromised.
alt
Approvals for first-of-a-kind drugs climbed last year, pushing the annual tally of new U.S. drugs to its highest level in 19 years. The rising figures reflect an industry-wide focus on drugs for rare and hard-to-treat diseases, which often come with streamlined reviews, extra patent protections and higher price tags.
alt
 AIIMS in collaboration with France-based FAM-Medical Academy Foundation and the French embassy in India has decided to develop cheaper medicines for cancer and cardiovascular diseases.
alt
Sun Pharmaceutical Industries has inked a pact with Israel's Technion university to develop anti-cancer drugs.






Loading...
english news
NEWS ON ONE CLICK